Neurology® Podcast

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

Informações:

Sinopsis

Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.  Read the related article in The New England Journal of Medicine.  Disclosures can be found at Neurology.org.